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Abstract
BACKGROUND: Low temperature plasma (LTP) was recently shown to be potentially useful for biomedical applications
such as bleeding cessation, cancer treatment, and wound healing, among others. Keratinocytes are a major cell type that
migrates directionally into the wound bed, and their proliferation leads to complete wound closure during the cutaneous
repair/regeneration process. However, the beneficial effects of LTP on human keratinocytes have not been well studied.
Therefore, we investigated migration, growth factor production, and cytokine secretion in primary human keratinocytes
after LTP treatment.
METHODS: Primary cultured keratinocytes were obtained from human skin biopsies. Cell viability was measured with
the EZ-Cytox cell viability assay, cell migration was evaluated by an in vitro wound healing assay, gene expression was
analyzed by quantitative real-time polymerase chain reaction, and protein expression was measured by enzyme-linked
immunosorbent assays and western blotting after LTP treatment.
RESULTS: Cell migration, the secretion of several cytokines, and gene and protein levels of angiogenic growth factors
increased in LTP-treated human keratinocytes without associated cell toxicity. LTP treatment also significantly induced the
expression of hypoxia inducible factor-1a (HIF-1a), an upstream regulator of angiogenesis. Further, the inhibition of HIF-
1a expression blocked the production of angiogenic growth factors induced by LTP in human keratinocytes.
CONCLUSION: Our results suggest that LTP treatment is an effective approach to modulate wound healing-related
molecules in epidermal keratinocytes and might promote angiogenesis, leading to improved wound healing.
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1 Introduction
Low temperature plasma (LTP) is formed by electric dis-
charge drilling for argon or helium under atmospheric
pressure at room temperature, and consists of electric
fields, a variety of reactive species, and UV emissions that
are responsible for multiple biological effects [1–4].
Studies have demonstrated the beneficial effects of LTP in
biomedical fields, including antimicrobial, antitumor, and
wound repair activities [1, 4].
One previous study investigated the safety of an LTP
device by treating human dermal fibroblasts, and the results
indicated that it can be safely used for therapeutic treat-
ment [5]. LTP treatment at low doses does not induce
toxicity, and instead it was found to induce porcine aortic
endothelial cell proliferation, whereas longer exposures
have been shown to lead to cell death [6]. Moreover, its
therapeutic potential for wound healing was systematically
investigated using human dermal fibroblasts, and it was
demonstrated that LTP treatment modulates cell parame-
ters relevant to wound healing, such as the promotion of
cell motility in an in vitro wound healing assay and the
induction of both gene and protein expression of MCP-1,
IL-6, and TGF-b1, which are important cytokines for
wound repair [7]. In addition, several animal studies have
demonstrated accelerated wound healing after LTP treat-
ment [7–9], based on one such mechanism, specifically the
stimulation of inflammatory responses [7]. Furthermore, in
clinical studies, daily treatment with plasma significantly
reduced bacterial counts in chronically-infected wounds
[10] and enhanced re-epithelialization, wherein fewer
blood scabs and fibrin layers were observed, without any
inflammation in the wound of the donor site, in a placebo-
controlled randomized clinical study [11]. Whereas the
development of LTP has approached clinical applications,
the mechanisms underlying its effects on mammalian cells
and tissues during wound repair are not entirely known.
Keratinocytes comprise the major cellular component of
the skin epidermis and have important roles in the complex
mechanisms underlying the initiation, maintenance, and
completion of the cutaneous wound healing process. At the
early stages after injury, keratinocytes begin to migrate,
close to the wound, and release a number of pro-inflam-
matory cytokines, chemokines, and growth factors that can
stimulate not only keratinocytes themselves, but also other
inflammatory cells and fibroblasts [12]. In particular, the
interactions between keratinocytes and fibroblasts, which
occur in a paracrine manner via growth factors, play an
extremely important role in the completion of wound clo-
sure during wound healing [13, 14].
Keratinocytes are also an important source of angio-
genic growth factors such as platelet-derived growth factor
(PDGF) [12], heparin-binding EGF-like growth factor
(HB-EGF) [15], and vascular endothelial growth factor
(VEGF) [16], all of which stimulate the migration of
endothelial cells to the wound site and contribute to
angiogenesis. HB-EGF and PDGF also stimulate fibroblast
proliferation, differentiation, and extracellular matrix
(ECM) production [13]. During normal wound healing,
VEGF is abundantly expressed in keratinocytes at the edge
of the wound [17]. In contrast, defective the VEGF mRNA
expression, might be associated with delayed wound repair
in diabetic db/db mice [16].
Until now, there have been few reports on the effects of
LTP on primary human epidermal keratinocytes. There-
fore, in this study, we investigated migration, growth factor
production, and cytokine secretion in keratinocytes after
LTP treatment. Furthermore, we evaluated the expression
of angiogenic growth factors induced by LTP via HIF-1a
upregulation.
2 Materials and methods
2.1 Primary human epidermal keratinocyte culture
Skin biopsies of volunteer were collected from Hangang
Sacred Heart Hospital. Informed written consent was
obtained from all patients who participated in this study,
and the study protocol was approved by the institutional
review board of Hallym University Hangang Sacred Heart
Hospital (2018-018). Tissues were repeatedly washed five
times with cold phosphate buffered saline (PBS) and 70%
alcohol for medical disinfection. The tissues were then cut
to a width of approximately 2–4 mm and digested with
dispase II (1.0 unit/ml, 30 ml; Gibco, Life Technologies,
Carlsbad, CA, USA) solution and agitated at 4 C for
16–21 h. The next day, the epidermis was separated from
tissues using sterile forceps, and then digested with 0.125%
trypsin (Gibco, Life Technologies, Carlsbad, CA, USA) for
15 min at 37 C. The samples were treated with KGM-
GoldTM keratinocyte growth medium containing supple-
ments (Lonza Bioscience, Basel, Switzerland) to inactivate
the trypsin. After filtering and centrifugation at 12009g for
3 min, the pellet was suspended in keratinocyte culture
media and cultured at 37 C in a humidified atmosphere
containing 5% CO2. Cells from the second passage were
applied to subsequent experiments.
2.2 LTP device
The LTP system was as used in our previous study [18].
The LTP was a developed dielectric barrier discharge
device, and applied 13 kHz of frequency, 5.9 kV of volt-
age, and 42 W of electric power. The working gas for LTP
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generation was a mixture of 5000 ccm of helium and 50
ccm of air at 28 ± 2 C.
2.3 LTP treatment
Keratinocytes were seeded in 35-mm cell culture dishes at
a density of 5 9 104 cells, and cultured for 2 days. Culture
dishes were washed once with Dulbecco’s phosphate buf-
fered saline (DPBS) and added to 1.2 ml of DPBS before
LTP treatment. Untreated dishes were subjected to the
same process. The distance between the LTP torch and
culture dish was 3 cm and the treatment diameter was
2 cm. The cells were treated with LTP for 30 s, 1 min, or
3 min, depending on the experiment. Analyses were per-
formed 6 and/or 24 h after LTP treatment.
2.4 Cell viability assay
Keratinocyte viability was measured by an improved MTT
assay method (EZ-Cytox, Dogen, Seoul, Korea) according
to the manufacturer’s instructions. The final value was
calculated according to the following formulae: sample
absorbance - background absorbance = original absor-
bance; original absorbance/control absorbance 9 100 =
% viability.
2.5 Cell migration assay
Keratinocyte migration was measured by wound healing
assays in 35 mm l-dishes with 2-well culture inserts (Ibidi
GmbH, Planegg, Germany) according to the manufac-
turer’s instructions. Keratinocytes were plated in the cul-
ture insert dish at a density of 2 9 104 cells per well and
cultured for 24 h. The culture insert was then withdrawn,
which produced a defined cell-free wound of
500 ± 50 lm. Mitomycin C (Sigma, St. Louis, MO, USA)
was added at 5 lg/ml to the cell culture medium to inhibit
cell proliferation during migration. The images of cell
migration in the wound area were captured 6 and 24 h after
exposure to LTP for 30 s or 3 min using a light microscope
(IX 70, Olympus, Tokyo, Japan). The migration was nor-
malized to that of untreated keratinocytes as a control,
which was set to 100%, and expressed as a fold-change.
2.6 Cytokine array
The supernatants of keratinocyte cultures were collected
24 h after exposure to LTP for 1 or 3 min. The super-
natants from untreated cells were used as controls. Cyto-
kine levels were measured by cytokine arrays (R&D,
Minneapolis, MN, USA), which included nine cytokine
targets, specifically GM-CSF, IL-1b, IL-4, IL-6, IL-8, IL-
10, IL-17, IL-12, and IL-13.
2.7 Enzyme-linked immunosorbent assay
The supernatants of keratinocyte cultures were collected
24 h after exposure to LTP for 30 s or 3 min, or from
untreated control cells, and were analyzed by enzyme-
linked immunosorbent assay (ELISA) (Cusabio Technol-
ogy, Wuhan, China) for eight selected molecular targets as
follows: PDGF-A, PDGF-B, VEGF-A, HB-EGF, vascular
angiopoietin-1 (Ang-1), angiopoietin-2 (Ang-2), fibroblast
growth factor 2 (FGF-2), and fibroblast growth factor 10
(FGF-10). For the inhibitor study, after exposure to LTP for
3 min and then immediate treatment with a HIF1a inhibitor
[19], 30 lM of CAY10585 (Cayman Chemical, Ann
Arbor, MI, USA) was added for 24 h. Unexposed cells
were treated with dimethyl sulfoxide (DMSO).
2.8 Quantitative real-time PCR
The keratinocytes were harvested 24 h after LTP treatment
for 30 s or 3 min and lysed with Trizol (Promega, Madi-
son, WI, USA). Total RNA was extracted with a column-
based total RNA extraction kit (MG-Med Geumchun-gu,
Seoul, Korea) according to the manufacturer’s instructions.
RNA concentration measurements, cDNA synthesis, and
quantitative real-time PCR (qPCR) were conducted as
previously described [18]. Sequences of primers are listed
in Table 1. The mRNA expression of target genes was
normalized based on the 2 - DDCt ratio [20].
2.9 Western blotting analysis
Keratinocytes were exposed to LTP for 3 min, immediately
incubated with 30 lL CAY10585, and harvested 24 h
after LTP treatment. Cells were lysed in ice-cold RIPA
buffer (Biosesang, Seongnam, Gyeonggi-do, Korea) with a
protease inhibitor cocktail and complete phosphatase
inhibitor (Sigma, St. Louis, MO, USA) pre-added. The
samples were incubated for 30 min at 4 C with constant
agitation, and centrifuged for 30 min (30,0009g, 4 C).
Protein concentration was measured with a Quick start
Bradford protein assay kit (Bio-Rad, Irvine, CA, USA).
Lysates were mixed with 5 9 reducing sample buffer
(Biosesang, Seongnam, Gyeonggi-do, Korea) and heated
for 3 min at 95 C. The samples were then loaded for gel
electrophoresis, electro-transferred onto polyvinylidene
difluoride (PVDF) membranes, and then blocked with 5%
(w/v) skim milk in tris-buffered saline containing 0.1%
tween-20 (TBST) at room temperature (RT). Membranes
were then incubated with polyclonal rabbit anti-HIF1a
primary antibody (1:500, Santa Cruz, CA, USA) or poly-
clonal rabbit anti-b-actin antibody (1:2000, Cell Signaling,
Danvers, MA, USA) for 18 h at 4 C. Samples were then
incubated with horseradish peroxidase (HRP)-conjugated
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goat anti-rabbit IgG antibody, as the secondary antibody
(1:3000, Merck Millipore, Billerica, MA, USA), for 2 h at
RT. The membranes were developed with PierceTM ECL
Western Blotting Substrate (Thermo Fisher Scientific,
Carlsbad, CA, USA), and imaged on a chemiluminescence
imaging system (WAE-6100, Atto, Tokyo, Japan). The
intensity of band images was analyzed with CS analyzer 4
software and then normalized to b-actin levels.
2.10 Statistical analysis
Results are expressed as the mean ± standard error (S.E.).
Comparisons between groups were performed using PASW
statistics 24 (SPSS Inc., Chicago, IL, USA), applying the
Mann–Whitney U test. Differences were considered sta-
tistically significant at p\ 0.05.
3 Results
3.1 LTP maintains cell viability and enhances
in vitro wound healing
To investigate cell viability after LTP treatment, the EZ-
Cytox cell viability assays were conducted to assess the
cytotoxic effects of this treatment towards keratinocytes.
According to the results, keratinocyte viability was not
affected by LTP exposure (Fig. 1A). Moreover, we per-
formed an in vitro wound healing assay in an insert l-dish
culture system 6 h and 24 h after LTP exposure for 30 s or
3 min. To inhibit the effects of cell proliferation during
migration, mitomycin C (5 mg/ml) was added to the cul-
ture medium for 24 h after LTP treatment. Keratinocyte
migration significantly increased 24 h after LTP exposure
for 3 min compared to that in the untreated control group
(p\ 0.05; Fig. 1B, C).
3.2 LTP increases cytokine production
in keratinocytes
To determine whether LTP treatment modulates cytokine
secretion, we performed a cytokine array with the super-
natant of keratinocytes after LTP treatment. According to
our data, the level of GM-CSF significantly decreased at
24 h in supernatants of keratinocyte cultures after exposure
to LTP for 1 or 3 min. However, the levels of IL-6, IL-10,
and IL-17 significantly increased in the keratinocyte cul-
ture medium 24 h after exposure to LTP for 3 min
(Table 2). Although the levels of IL-1b and IL-8 were
slightly reduced, there was no significant difference. At the
same time, IL-4, IL-12, and IL-13 were not detected
(Table 2).
3.3 LTP increases the expressions of angiogenic
genes and proteins in keratinocytes
Next, we measured the mRNA expression of angiogenic
growth factors by real-time PCR. Ang-1, Ang-2, VEGF-A,
HB-EGF, FGF-2, and FGF-10 mRNA levels were signifi-
cantly increased 24 h after exposure to LTP for 30 s,
compared to those in untreated controls (p\ 0.05;
Fig. 2A–F). Furthermore, LTP treatment for 3 min more
robustly induced the expression of these markers compared
to that after exposure for 30 s (p\ 0.05; Fig. 2A–F). In
addition, PDGF-AA and PDGF-BB were highly induced
24 h after exposure to LTP for 3 min, compared to that in
untreated cells (p\ 0.05; Fig. 2G, H).
We then determined the protein expression of angio-
genic factors in the cell culture medium, 24 h after LTP
treatment, by ELISA. The levels of Ang-1, Ang-2, VEGF-
A, HB-EGF, FGF-2, and FGF-10 were significantly
increased 24 h after exposure to LTP for 3 min, compared
to those in the untreated controls (p\ 0.05; Fig. 3A–F).
Furthermore, the levels of PDGF-A and PDGF-B were
Table 1 Real-time PCR primer
sequences
Gene Forward (50 ? 30) Reverse (50 ? 30)
ANG-1 CAACCTTGTCAATCTTTGCACT TCTGCACAGTCTCTAAATGGT
ANG-2 TAAGGACCCCACTGTTGCTA TAGATGCCATTCGTGGTGTG
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significantly increased 24 h after exposure to LTP for 30 s
and 3 min, compared to those in the untreated control
group (p\ 0.05; Fig. 3G, H).
3.4 LTP increases the production of angiogenic
cytokines in a HIF-1a-dependent manner
in keratinocytes
To confirm whether the expression of angiogenic growth
factors is controlled by HIF-1a, keratinocytes were treated
with CAY10585 for 24 h, which is an inhibitor of HIF-1a
accumulation and transcriptional activity, after exposure to
LTP for 3 min. Subsequently, the protein expression of
HIF-1a was evaluated by western blot analysis. HIF-1a
expression in the cell lysate was significantly induced 24 h
after exposure to LTP for 3 min, compared to that in
untreated keratinocytes (p\ 0.05; Fig. 4A). However,
CAY10585 treatment suppressed LTP-induced HIF-1a
expression, compared to that in the untreated controls
(p\ 0.05; Fig. 4A). Similarly, levels of VEGF-A, Ang-1,
and Ang-2 were significantly induced 24 h after exposure
to LTP for 3 min, compared to those in the untreated
keratinocytes (p\ 0.05; Fig. 4B–D). Moreover,
Fig. 1 Cell viability and migration of primary human skin ker-
atinocytes after LTP treatment. LTP treatment maintains viability and
induces migration of keratinocyte. A Keratinocyte viability was
expressed as a percentage value of untreated cells. The untreated
control are regarded as 100%. Values are expressed as mean ± SE
from three independent experiments. *p\ 0.05 versus the corre-
sponding untreated control. B Photographs of keratinocyte migration
at 6 and 24 h after exposure to LTP for 30 s or 3 min. Scale bar,
500 lm. C Quantification of keratinocyte migrations was expressed
as a fold change, normalized to untreated cell (set to 100%). Data are
expressed as mean ± S.E. from three independent experiments.
*p\ 0.05 versus the corresponding untreated control
Table 2 LTP treatment induces cytokine expression
Cytokine Multiplex cytokine assay
1 min 3 min
GM-CSF Fold change
(LTP/control)
0.69 ± 0.134 0.76 ± 0.101
P value 0.0303* 0.0306*
IL-1b Fold change
(LTP/control)
0.94 ± 0.063 0.86 ± 0.163
P value 0.257 0.187
IL-6 Fold change
(LTP/control)
0.90 ± 0.010 1.11 ± 0.024
P value 0.055 0.026*
IL-8 Fold change
(LTP/control)
0.91 ± 0.151 0.92 ± 0.162
P value 0.216 0.262
IL-10 Fold change
(LTP/control)
1.09 ± 0.013 1.15 ± 0.016
P value 0.028* 0.022*
IL-17 Fold change
(LTP/control)
1.03 ± 0.104 1.21 ± 0.012




Multiplex cytokine array analysis was performed using cell culture
media from 24 h after LTP treatment for 1 min or 3 min or form
untreated cells. The results are expressed as a fold change, untreated
samples are marked as value 1. Each sample was assayed in duplicate,
and the experiments were performed in three times independently.
Data are expressed as mean ± SE *p\ 0.05 versus the control group
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CAY10585 treatment significantly blocked the LTP-me-
diated increase in VEGF-A, Ang-1, and Ang-2 in the
keratinocyte culture medium (p\ 0.05; Fig. 4B–D).
4 Discussion
Over the past 10 years, plasma applications have been
gradually developed for the field of medicine. LTP has
been shown to be anti-bacterial, induce the stimulation of
dermal cell migration and proliferation, and modulate
redox signaling during wound regeneration [21, 22].
However, before plasma becomes a medical device, its
efficacy and safety should be further evaluated at both the
cellular and organism levels. In the present study, we
aimed to identify whether cell migration, the expression of
different cytokines, and growth factor production are
induced by LTP without cytotoxicity in human primary
keratinocytes.
We found that LTP treatment for 3 min did not affect
keratinocyte viability (Fig. 1A), indicating that it is a safe
dose for mammalian cells or for future in vivo studies.
Moreover, we observed that LTP influences keratinocyte
migration, as determined by a scratch wound healing assay,
where cells were treated with mitomycin C to eliminate the
effect of cell proliferation (Fig. 1B, C). These results are in
consistent with a study by Schmidt et al. [9] which showed
enhanced HaCaT cell migration with an indirect plasma
treatment and indicated that these phenomena were related
Fig. 3 Protein expressions of angiogenic growth factors after LTP
treatment. A–H The concentration of Ang-1, Ang-2, VEGF-A, HB-
EGF, FGF-2, FGF-10, PDGF-AA and PDGF-BB were measured by
ELISA in keratinocytes cell culture supernatants 6 and 24 h after LTP
treatment for 30 s or 3 min. Each sample assessed in duplicate, and
the analysis performed three times independently. Data are the
mean ± SE *p\ 0.05 versus the untreated control group
Fig. 2 mRNA expression of angiogenic growth factors after LTP
treatment. Cell culture dishes were rinsed once with DPBS before
exposure to LTP, then added 1.2 ml DPBS. Untreated dishes also
undergone the above process. A–H The mRNA expression of Ang-1,
Ang-2, VEGF-A, HB-EGF, FGF-2, FGF-10, PDGF-AA and PDGF-
BB was measured 6 and 24 h after LTP treatment for 30 s or 3 min.
The mRNA expression was calculated as ratio = 2 -44Ct,
untreated cells are marked as value 1, and data are the mean ± SE
from three independent experiments. *p\ 0.05 versus the corre-
sponding untreated control group
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to changes in junction proteins and adhesion molecules
induced by LTP. Moreover, there is evidence that ERK
activation also contributes to the cell migration induced by
LTP [23]. In addition, animal experiments showed that pro-
inflammatory cytokines and growth factors are abundant at
the wound site, suggesting that they play an important role
in keratinocyte migration [24, 25]. We found that LTP
induced the secretion of IL-6 (Table 2), VEGF-A, HB-
EGF, FGF2, and FGF-10 (Figs. 2C–F, 3C–F) in ker-
atinocytes. These factors can exert multiple effects on
keratinocytes individually or in combination, particularly
with respect to cell proliferation and migration [25]. Thus,
we suggest that enhanced keratinocyte migration is par-
tially a response to the production of pro-inflammatory
cytokines and growth factors induced by LTP.
LTP also treatment induced the expression of pro-in-
flammatory cytokines including IL-6 and IL-17 and the
anti-inflammatory cytokine IL-10 (Table 2). In an in vitro
study, IL-17 induced the expression of antimicrobial pep-
tides in keratinocytes [26]. In addition, IL-17 administra-
tion promoted scar formation by increasing the number of
macrophages in a cutaneous excisional mouse model [27].
Conversely, blocking or the genetic deletion of IL-17
resulted in delayed wound closure in animals [28]. The
cytokine IL-6 induces keratinocyte proliferation in vitro.
IL-6 knockout mice were shown to exhibit a delay in re-
epithelialization and impaired granulation tissue formation;
in contrast, excessive IL-6 leads to cutaneous scarring
[29, 30]. IL-10 inhibits the overexpression of chemokines
and pro-inflammatory cytokines including IL-6 and TNF-a
in vivo. Lenti-IL-10 injection to a wound was found to
result in reduced inflammation, scar-less healing, and the
restoration of normal dermal architecture [31, 32]. There-
fore, we suggest the LTP treatment might have an impor-
tant effect in regulating the coordinated expression of
multiple cytokines for the purpose of maintaining normal
wound repair. Moreover, the expression of pro-inflamma-
tory cytokines was found to be prominently decreased in
wound healing-impaired mice [33] and exaggerated
inflammation is a necessary prerequisite for scar formation.
For example, the enhanced activity of pro-inflammatory
cytokines increases the concentration of profibrotic
cytokines such as TGF-b, which might induce hypertrophic
scars in burn or infected wounds [34].
It is well known that angiogenesis plays an important
role in wound healing. Newly formed blood vessels con-
tribute to the formation of granulation tissue and provides
nutrition and oxygen to support growing tissues [35]. HIF-
1a is widely recognized as a controller of angiogenesis, as
it regulates the expression various pro-angiogenic factors
including VEGF and FGF [36]. In our study, we observed
the increased expression of intracellular HIF-1a following
LTP treatment in keratinocytes (Fig. 4A). Moreover, LTP
treatment also significantly induced both the mRNA and
protein expression of angiogenic growth factors including
Ang-1, Ang-2, VEGF-A, HB-EGF, PDGF-AA, PDGF-BB,
FGF-2, and FGF-7, as measured by qPCR and ELISA
(Figs. 2, 3). However, treatment with a HIF-1a inhibitor,
Fig. 4 HIF-1a inhibitor blocked the LTP-induced production of
angiogenic growth factor in keratinocytes. A Expression of HIF-1a in
keratinocytes after exposure to LTP was evaluated by western
blotting. CAY10585 was administrated with 30 lM for 24 h imme-
diately after LTP treatment for 3 min. The intensity of each protein
band measured and HIF-1a expression was normalized to the ratio of
b-actin. *p\ 0.05 versus the untreated control group or CAY10585
treated group. B–D The levels of VEGF-A, Ang-1, and Ang-2
measured by ELISA in keratinocyte cell culture supernatant 24 h after
LTP treatment for 3 min. All data are expressed as mean ± SE from
three independent experiments. Data are expressed as mean ± SE
*p\ 0.05 versus the untreated control group or CAY10585 treated
group
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CAY10585, blocked the LTP-induced upregulation of
angiogenic growth factors (Fig. 4). A recent study showed
that LTP treatment increases angiogenesis in an animal
pressure ulcer model [8]. Several studies also suggested
specific role for HIF-1a in cell migration. In one study, th
HIF-1a inhibitor vitexin significantly inhibited the migra-
tion of rat pheochromocytoma PC12 cells [1, 37]. The
migration of embryonic fibroblasts cultured from HIF-1a-
knockout mice was also found to be significantly reduced
when compared with that of wild-type cells. However, this
phenomenon was partially rescued by HIF-1a gene transfer
[2, 38]. Furthermore, HIF-1a knock-down by siRNA
transfection in HaCaT keratinocytes inhibited their
migration [3, 39]. This evidence clearly shows that HIF-1a
is an upstream regulator of cell migration. Our results
showed that LTP treatment upregulates HIF-1a expression
in keratinocytes, thereby increasing their migration.
In summary, this study demonstrated that LTP improves
wound healing in human primary keratinocytes by induc-
ing inflammation-relevant cytokines, cell migration, and
the production of angiogenic factors, which are mediated
HIF-1a upregulation in response to LTP. Impaired angio-
genesis has been shown by many studies to be associated
with pathological wound repair seen in delayed and
impaired wound healing animal models or chronic, non-
healing wound repair in patients. Keratinocyte-derived
angiogenic growth factors are critical for impaired angio-
genesis. Therefore, we believe that LTP might improve
angiogenesis during delayed wound repair. Future research
will confirm the results of the current in vitro experiments
using an animal study and will evaluate other beneficial
effects of LTP treatment in vivo.
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